获取途径

作者

Jianlei Wu, Yaru Zhang, Haibo Zhang, Yan Li, Zhihui Jie, Shan Kang

作者单位

Affiliations ¹ Department of Gynecological Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China. ² Department of Obstetrics and Gynaecology, Hebei Medical University, Fourth Hospital, Shijiazhuang, China. ³ Department of Obstetrics and Gynaecology, The Second Affiliated Hospital of Shandong First Medical University, Tai'an, China.

刊名

Medicine

年份

2025

卷号

Vol.104 No.41

页码

e44921

ISSN

1536-5964

关键词

TIM-3 epithelial ovarian cancer prognosis tumor cells tumor microenvironment.

摘要

T-cell immunoglobulin and mucin domain-containing molecule 3 has been reported to be overexpressed and associated with poor prognosis in solid tumors. However, its features and prognostic value in epithelial ovarian cancer remain undetermined. In this study, we aimed to characterize TIM-3 expression and its prognostic significance in patients with EOC. A total of 134 EOC patients and 20 healthy controls from North China were included. TIM-3 mRNA and protein expression in EOC tumor tissues and ...更多

T-cell immunoglobulin and mucin domain-containing molecule 3 has been reported to be overexpressed and associated with poor prognosis in solid tumors. However, its features and prognostic value in epithelial ovarian cancer remain undetermined. In this study, we aimed to characterize TIM-3 expression and its prognostic significance in patients with EOC. A total of 134 EOC patients and 20 healthy controls from North China were included. TIM-3 mRNA and protein expression in EOC tumor tissues and benign ovarian tissues were detected by real-time quantitative PCR and immunohistochemistry. The distribution of TIM-3 protein in different regions of EOC tissue were evaluated by multicolor immunofluorescence. Associations between their expression and clinicopathological parameters as well as survival analyses were performed. The results showed that high expression levels of TIM-3 mRNA were significantly associated with shorter progression-free survival and overall survival durations in EOC patients. High TIM-3 expression levels in tumor cells had shorter PFS and OS compared with those low TIM-3 expression levels. Similarly, TIM-3 in the tumor microenvironment was also an independent factor that affected the clinical outcome of EOC patients . These findings indicated that IM-3 may be a potential biomarker for predicting prognosis and immunotherapy efficacy in patients with EOC, exerting different roles on tumor cells and tumor microenvironment.收起

文献类型

期刊